Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance.

The renewed interest in bacteriophage therapy as a response to antimicrobial resistance (AMR) has exposed a critical barrier to its scalable implementation: the lack of structured infrastructure to support precision phage deployment. Due to their narrow host specificity, bacteriophages require timely access to well-matched candidates, making ad hoc isolation and informal exchange insufficient for routine therapeutic use. In this Perspective, we argue that phage biobanks must be redefined as enabling infrastructure rather than passive repositories. We propose that next-generation phage biobanks should integrate curated biological diversity, systematic genomic and functional qualification, and predictive capacity to support rapid phage-host matching. Together, these elements transform biobanks into decision-support systems capable of informing translational applications under time-sensitive conditions. This infrastructural model is particularly relevant within a One Health framework, where resistant pathogens circulate across human, veterinary, agricultural, and environmental domains. Rather than reviewing methodologies, we outline conceptual principles to guide the design of phage biobanks as integrated, predictive, and sustainable assets. We contend that the future impact of phage therapy will depend less on individual phage discovery than on the development of interoperable biobank infrastructures that enable precision antimicrobial interventions at scale.

• Publication year

  2026

• Venue

  Frontiers in Antibiotics

• Publication date

  2026-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/frabi.2026.1772871PMID 41756397PMCID PMC12933349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects

  2025cited by this paper
• Gut Phage Biobank: a collection of bacteriophages targeting human commensal bacteria

  2025cited by this paper
• Addressing methodological bias in phageome research to clarify bacteriophage diversity.

  2025cited by this paper
• Phage to ESKAPE: Personalizing Therapy for MDR Infections—A Comprehensive Clinical Review

  2025cited by this paper
• An Overview of the Epidemiology of Multidrug Resistance and Bacterial Resistance Mechanisms: What Solutions Are Available? A Comprehensive Review

  2025cited by this paper
• How the world of biobanking is changing with artificial intelligence

  2025cited by this paper
• Advanced Strategies in Phage Research: Innovations, Applications, and Challenges

  2025cited by this paper
• Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways

  2025cited by this paper
• Genomic insights into bacteriophages: a new frontier in AMR detection and phage therapy

  2025cited by this paper
• Progress in phage therapy in response to antimicrobial resistance.

  2025cited by this paper
• Virological and Pharmaceutical Properties of Clinically Relevant Phages

  2025cited by this paper
• The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance

  2025cited by this paper
• Viral genome sequencing methods: benefits and pitfalls of current approaches

  2024cited by this paper
• Between Centralization and Fragmentation: The Past, Present, and Future of Phage Collections

  2024cited by this paper
• Advances in phage–host interaction prediction: in silico method enhances the development of phage therapies

  2024cited by this paper
• Phage-driven coevolution reveals trade-off between antibiotic and phage resistance in Salmonella anatum

  2024cited by this paper
• The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae

  2024cited by this paper
• A Comprehensive Review on Phage Therapy and Phage-Based Drug Development

  2024cited by this paper
• Engineering Phages to Fight Multidrug-Resistant Bacteria

  2024cited by this paper
• Bacteriophages: Status quo and emerging trends toward one health approach.

  2023cited by this paper
• Phage Therapy—Challenges, Opportunities and Future Prospects

  2023cited by this paper
• The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era

  2023cited by this paper
• The Future of Clinical Phage Therapy in the United Kingdom

  2023cited by this paper
• Phage therapy: From biological mechanisms to future directions.

  2023cited by this paper
• A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens

  2022cited by this paper
• Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective

  2021cited by this paper
• Phage Biobank: Present Challenges and Future Perspectives.

  2021cited by this paper
• Phage Annotation Guide: Guidelines for Assembly and High-Quality Annotation

  2021cited by this paper
• Mechanisms and clinical importance of bacteriophage resistance

  2021cited by this paper
• Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way?

  2020cited by this paper
• PHERI—Phage Host ExploRation Pipeline

  2020cited by this paper
• Standardized bacteriophage purification for personalized phage therapy

  2020cited by this paper

• No citing papers are available for this paper.